前海开源中药股票A(005505)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-89,387,527.67 |
-42,033,444.10 |
-28,053,872.31 |
-97,034,167.77 |
| 利息合计 |
129,083.40 |
382,746.92 |
214,258.06 |
800,559.04 |
| 其中:存款利息收入 |
129,083.40 |
382,746.92 |
214,258.06 |
800,559.04 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-45,724,801.17 |
-20,613,989.45 |
-2,792,475.49 |
-234,722,030.08 |
| 其中:股票投资收益 |
-58,963,639.37 |
-37,070,651.19 |
-11,988,425.36 |
-275,653,464.77 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
13,238,838.20 |
16,456,661.74 |
9,195,949.87 |
40,931,434.69 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-44,105,020.27 |
-23,402,220.18 |
-25,989,818.16 |
134,213,941.26 |
| 其他收入 |
313,210.37 |
1,600,018.61 |
514,163.28 |
2,673,362.01 |
| 费用 |
4,374,500.96 |
11,609,474.87 |
6,154,255.58 |
20,773,706.44 |
| 管理人报酬 |
3,356,173.81 |
9,026,283.85 |
4,807,338.61 |
16,220,998.76 |
| 基金托管费 |
559,362.34 |
1,504,380.69 |
801,223.12 |
2,703,499.81 |
| 销售服务费 |
355,745.26 |
870,810.33 |
442,474.30 |
1,631,207.87 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
103,219.55 |
208,000.00 |
103,219.55 |
218,000.00 |
| 利润总额 |
-93,762,028.63 |
-53,642,918.97 |
-34,208,127.89 |
-117,807,874.21 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年